Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 27 Feb 2026 for Avidity Biosciences, Inc.. Read the official filing
Filing timeline
BuySaleEric Mosbrooker
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Eric Mosbrooker: trading record in brief
Eric Mosbrooker (senior executive) discloses dealings in Avidity Biosciences, Inc. to SEC (Form 4). The record holds 7 filings, for trades running from 6 January 2025 to 27 February 2026.
No open-market purchase appears, only 1 sale worth €254k. Other entries cover 2 share grants and 3 option exercises.
The record was last updated on 27 February 2026 with a transaction in Avidity Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Eric Mosbrooker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
79,413 sharesCommon StockSEC:0001193125-26-082120:0
72,000 shares0Common StockSEC:0001599901-25-000221:0
6,562 shares@ US$9.050.022% mcap50.0% of flowCommon StockSEC:0001599901-25-000192:0
6,562 shares@ US$45.378171.5% of flowCommon StockSEC:0001599901-25-000192:1
6,563 shares@ US$9.053.8% of flowCommon StockSEC:0001599901-25-000173:0
124,687 shares@ US$9.0576.1% of flowCommon StockSEC:0001599901-25-000157:0
25,000 shares0Common StockSEC:0001599901-25-000015:0
7 of 7 declarations
